# Beam Therapeutics Inc. (BEAM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Beam Therapeutics Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BEAM/mda/fy2025/): filed 2026-02-24; accession 0001193125-26-065194 (https://www.sec.gov/Archives/edgar/data/1745999/000119312526065194/beam-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BEAM/mda/fy2024/): filed 2025-02-25; accession 0000950170-25-026076 (https://www.sec.gov/Archives/edgar/data/1745999/000095017025026076/beam-20241231.htm)
- [FY 2023 MD&A](/company/BEAM/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-020622 (https://www.sec.gov/Archives/edgar/data/1745999/000095017024020622/beam-20231231.htm)
- [FY 2022 MD&A](/company/BEAM/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-004866 (https://www.sec.gov/Archives/edgar/data/1745999/000095017023004866/beam-20221231.htm)
- [FY 2021 MD&A](/company/BEAM/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002166 (https://www.sec.gov/Archives/edgar/data/1745999/000095017022002166/beam-20211231.htm)

Back to /company/BEAM/